Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19354ExperimentalSmall molecule
Hydrastine: Overview.
- Formula / weight
- C21H21NO6 · 383.4 g/mol (avg)
- Also known as
- (s)-6,7-dimethoxy-3-(r)-(6-methyl-5,6,7,8-tetrahydro-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)isobenzofuran-1(3h)-one · Hydrastine (constituent of goldenseal) · Phthalide (s)-6,7-dimethoxy-3-(r)-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-
- Code names
- NSC-757430
Resolves to
Structure
InChIKey
JZUTXVTYJDCMDU-MOPGFXCFSA-NSMILES[H][C@@]1(OC(=O)C2=C1C=CC(OC)=C2OC)[C@]1([H])N(C)CCC2=CC3=C(OCO3)C=C12What you can answer from here — as of September 23, 2026
Which companies are running trials of Hydrastine, in which indications and phases, and which of those programs are still active?